COMMUNIQUÉS West-GlobeNewswire

Antares Pharma to Report First Quarter 2019 Financial and Operating Results
18/04/2019
EWING, N.J., April 18, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first quarter 2019 financial results and recent operating progress before the market opens on [...]
ProQR nominates Bart Filius, COO and CFO at Galapagos and Theresa Heggie, Head of CEMEA at Alnylam for its Supervisory Board
18/04/2019
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
ProQR Announces Annual Meeting of Shareholders
18/04/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Teleflex Announces First Quarter 2019 Earnings Conference Call Information
18/04/2019
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, May 2, 2019 WAYNE, Pa., April 18, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2019 [...]
Mateon Enters into Merger Agreement with Oncotelic
18/04/2019
Forms Late Clinical-Stage Cancer Immunotherapy Company Focusing on TGF-β RNA Therapeutics SOUTH SAN FRANCISCO, Calif. and AGOURA HILLS, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) [...]
Next Green Wave Begins Cannabis Production
18/04/2019
NGW Authorized as Licensed Producer in Coalinga, California VANCOUVER, British Columbia, April 18, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) ("Next Green Wave", “NGW” or the " [...]
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, Inc. ("OncoMed") – Result of OncoMed Stockholder Meeting
18/04/2019
LONDON, April 18, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, announces today that stockholders of OncoMed (NASDAQ: OMED [...]
Nicox First Quarter 2019 Business Update and Financial Highlights
18/04/2019
Press Release Nicox First Quarter 2019 Business Update and Financial Highlights ………………………………………………………………………………………………………………………….. Total VYZULTA® prescriptions for the first quarter 2019 increased by 18% compared to the [...]
Nicox : Point d’activité et résumé financier du premier trimestre 2019
18/04/2019
Communiqué de presse Nicox : Point d’activité et résumé financier du premier trimestre 2019 ………………………………………………………………………………………………………………………….. • Augmentation de 18% du nombre total de prescriptions de VYZULTA ® pour le [...]
Genfit: GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC
18/04/2019
GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC FDA grants elafibranor Breakthrough Therapy Designation, based on Phase 2 data, for treatment of PBC (Primary [...]
Genfit : GENFIT annonce l’attribution de la Breakthrough Therapy Designation à elafibranor, par la FDA, pour le traitement de la PBC
18/04/2019
GENFIT annonce l’attribution de la Breakthrough Therapy Designation à elafibranor, par la FDA, pour le traitement de la PBC La FDA attribue à elafibranor la Breakthrough Therapy Designation, sur base des données de [...]
HOOKIPA Pharma Announces Pricing of Initial Public Offering
18/04/2019
NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus [...]
Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing
17/04/2019
RICHMOND HILL, Ontario, April 17, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Globus Medical Schedules First Quarter 2019 Earnings Release and Conference Call
17/04/2019
AUDUBON, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2019 after the [...]
St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine
17/04/2019
Licensing partnership for vector between St. Jude and Mustang Bio announced in Summer, 2018 This Phase 1/2 trial in newly diagnosed infants with XSCID continues to enroll at St. Jude, UCSF Benioff Children’s Hospital [...]
Profound Medical to Release First Quarter 2019 Financial Results on May 6 – Conference Call to Follow
17/04/2019
TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Conformis to Host First Quarter 2019 Financial Results Webcast on May 1, 2019
17/04/2019
BILLERICA, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for [...]
Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
17/04/2019
HAMILTON, Bermuda, April 17, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
Kane Biotech Announces Granting of Options
17/04/2019
WINNIPEG, Manitoba, April 17, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]

Pages